Smartphone-Based Monitoring of Quality of Life and Adverse Events After Neurosurgery: Prospective Cohort Study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Mobile Device Monitoring of Patient Well-Being and Complications Following Neurosurgical Procedures: A Prospective Cohort Investigation

  • By

  • Alexis Paul Romain Terrapon

  • Erik Schulz

  • Athina Firtinidou

  • Silvio Heinig

  • Lorenzo Bertulli

  • Felix Corr

  • Meltem Gönel

  • Maria Nikolaeva

  • Thomas Petutschnigg

  • Sivani Sivanrupan

  • Jakob Heimer

  • Menno R Germans

  • Christian Zweifel

  • Andreas Raabe

  • Philippe Schucht

  • Luca Regli

  • Marian Christoph Neidert

  • Oliver Bozinov

  • Linda Bättig

  • Martin Nikolaus Stienen

  • September 9, 2026

Share

Objective:

To assess the feasibility of collecting real-time data on patient well-being and adverse events (AEs) following neurosurgical procedures using a smartphone application.

Approach:
  • Study Design: A prospective, multicenter observational study utilizing the OP Tracker app to evaluate patients’ quality of life (QoL) and perioperative AEs from before neurosurgery through 1 year afterward.
Key Findings:
  • The OP Tracker app collects longitudinal self-reported information on well-being and AEs.
  • The study evaluates recruitment patterns, data completeness, accuracy of AE detection and grading, and early patient-reported outcome trends.
Limitations:
  • The study is in the initial phase, and findings are descriptive and interim.
  • Potential issues with user engagement and reporting quality in mobile applications were noted in earlier investigations.
Conclusion:

The OP Tracker app demonstrates potential for real-time assessment of patient outcomes in neurosurgery.

Original Source(s)

Smartphone-Based Monitoring of Quality of Life and Adverse Events After Neurosurgery: Prospective Cohort Study

  • by Alexis Paul Romain Terrapon, Erik Schulz, Athina Firtinidou, Silvio Heinig, Lorenzo Bertulli, Felix Corr, Meltem Gönel, Maria Nikolaeva, Thomas Petutschnigg, Sivani Sivanrupan, Jakob Heimer, Menno R Germans, Christian Zweifel, Andreas Raabe, Philippe Schucht, Luca Regli, Marian Christoph Neidert, Oliver Bozinov, Linda Bättig, Martin Nikolaus Stienen

  • September 9, 2026

Related Content

Serum lactate dehydrogenase is associated with the presence and extent of preoperative peritumoral edema in melanoma brain metastases

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

Role of the frontal aslant tract in language preservation and recovery after surgery: a multicenter analysis of patients with left frontal glioma